Dataset Information


Dysregulated mesenchymal PDGFR-β drives kidney fibrosis

ABSTRACT: Kidney fibrosis is characterized by expansion and activation of platelet-derived growth factor receptor-β (PDGFR-β) positive mesenchymal cells. To study the consequences of PDGFR-ß activation, we developed a model of primary renal fibrosis using transgenic mice with PDGFR-β activation specifically in renal mesenchymal cells, driving their pathological proliferation and phenotypic switch towards myofibroblasts. This resulted in progressive mesangioproliferative glomerulonephritis, mesangial sclerosis and interstitial fibrosis with progressive anemia due to loss of erythropoietin production by fibroblasts. We used microarrays to compare wildtype animals (Foxd1_wt Pdgfrb_wt) to animals with constitutive mesenchymal PDGFR-β activation (Foxd1_mt Pdgfrb V536A) in the kidney to identify target genes of PDGFR-β signaling. Overall design: To generate mice with a renal mesenchymal cell-specific, constitutively active PDGFR-β (Foxd1_mt Pdgfrb V536A), we used mice in which one wt Pdgfrb allele was substituted by a conditional knock-in of Pdgfrb with an activating point mutation (V536A) in the juxtamembrane domain of PDGFR-β, behind a floxed STOP cassette. Expression of the mutated Receptor occurs after Cre-recombinase excision. Cre-recombinase expression occurs under the FoxD1-promoter, which is active in renal mesenchymal precursors during development. Foxd1_mt Pdgfrb V536A mice were compared to wildtype littermates Foxd1_wt Pdgfrb_wt.

INSTRUMENT(S): [MTA-1_0] Affymetrix Mouse Transcriptome Array 1.0 [transcript (gene) CSV version]

ORGANISM(S): Mus musculus  

SUBMITTER: Bernd Denecke  

PROVIDER: GSE138819 | GEO | 2019-12-06


Dataset's files

Action DRS
GSE138819_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2

Similar Datasets

1969-12-31 | S-SCDT-EMM-2019-11021 | BioStudies
2020-01-01 | S-EPMC7059015 | BioStudies
2018-01-01 | S-EPMC5973593 | BioStudies
2016-01-01 | S-EPMC5113675 | BioStudies
1000-01-01 | S-EPMC5653645 | BioStudies
1000-01-01 | S-EPMC2810076 | BioStudies
2019-01-01 | S-EPMC6426711 | BioStudies
2021-09-23 | GSE184670 | GEO
2021-09-23 | GSE184671 | GEO
2013-01-01 | S-EPMC3675240 | BioStudies